Sirolimus (Rapamune®) for the treatment of anti-Hu associated paraneoplastic neurological syndromes

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-000793-20

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The main objective of the trial is to study the efficacy of sirolimus in paraneoplastic neurological syndromes associated with anti-Hu antibodies.


Critère d'inclusion

  • Paraneoplastic Neurological Syndromes associated with anti-Hu antibodies

Liens